233
Participants
Start Date
April 1, 2017
Primary Completion Date
August 25, 2023
Study Completion Date
August 25, 2023
Ibrexafungerp
Experimental Study Drug
FCRN Clinical Trial Centre, Three Rivers
Medical University Innsbruck, Innsbruck
Radboud University Medical Center, Department of Medicine Geert Grooteplein Zuid 8, Nijmegen
Medical University of Graz Department of Internal Medicine, Department of Pulmology, Section for Infectious Disease and Tropical Medicine, Graz
Memorial Sloan Kettering Cancer Center, New York
Weill Cornell Medical College, New York
Stony Brook University Medical Center, Stony Brook
University of Pittsburg Medical Center, Pittsburgh
Wake Forest Baptist Medical Center, Winston-Salem
Duke University Medical Center, Durham
Hospital General Universitario Gregorio Marañón, Madrid
Emory University Hospital Midtown, Atlanta
Augusta University, Augusta
Universitätsklinikum Essen, Klinik für Infektiologie, Essen
Hospital Universitari i Politecnic La Fe, Valencia
University of Michigan, Ann Arbor
Wayne State University, Detroit
Universitätsklinikum Köln, Klinik I für Innere Medizin, Cologne
University of Wisconsin, Madison
University of Minnesota, Minneapolis
Mayo Clinic, Rochester
Universitätsklinikum Frankfurt, Department of Internal Medicine II, Frankfurt
Washington University School of Medicine, St Louis
Aga Khan University, Karachi
University of Texas Health Science Center at Houston, Houston
LMU Klinikum der Universität München, Medizinische Klinik und Poliklinik III, Munich
University of California San Francisco, San Francisco
UC Davis Medical Center, Sacramento
University of Alabama at Birmingham, Birmingham
Massachusetts General Hospital, Boston
University of Texas Southwestern Medical Center Dallas, Dallas
Klinikum St. Georg gGmbH Department for Infectious Disease, Tropical Medicine and Nephrology, Leipzig
Johese Clinical Research, Lyttelton
Into Research, Groenkloof
Emmed Research, Pretoria
St. George's University of London, London
The University of Manchester, Manchester
Scynexis, Inc.
INDUSTRY